9th NovAliX Conference | Hybrid Event

Biophysics in Drug Discovery 2023 | US Edition

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Philadelphia, United States & Virtual    April 26-28, 2023

Committees


Conference Chairman

Chairman

Dr Jean-Paul RENAUD

Urania Therapeutics, Ostwald, France

Scientific Committe

Members

Prof. Michelle ARKIN

University of California, San Francisco, United States

Dr Claudio CIFERRI

Genentech, South San Francisco, United States

Dr MariJean EGGEN

Eli Lilly, Indianapolis, United States

Dr Daniel ERLANSON

Frontier Medicines, San Francisco, United States

Dr Jean-Paul RENAUD

Urania Therapeutics, Ostwald, France

Dr Holly SOUTTER

Broad Institute, Cambridge, United States

Dr Chaohong SUN

Abbvie, North Chicago, United States

Dr Daniel WYSS

Merck, Morristown, United States